Aarey Drugs Pharmaceuticals Ltd vs Alivus Life Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Aarey Drugs & Pharmaceuticals Ltd is ₹ 88.98 as of 18 May 13:45 . The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd changed from 8.3 on March 2021 to 23.9 on March 2025 . This represents a CAGR of 23.56% over 5 yearsThe P/E Ratio of Alivus Life Sciences Ltd changed from 13.4 on March 2022 to 27.2 on March 2025 . This represents a CAGR of 19.36% over 4 years The Market Cap of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 54.25 crore on March 2021 to ₹ 95.58 crore on March 2025 . This represents a CAGR of 11.99% over 5 yearsThe Market Cap of Alivus Life Sciences Ltd changed from ₹ 5624 crore on March 2022 to ₹ 13229 crore on March 2025 . This represents a CAGR of 23.84% over 4 years The revenue of Aarey Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 100.61 crore. This represent the decline of -100% The revenue of Alivus Life Sciences Ltd for the Mar '26 is ₹ 711.9 crore as compare to the Dec '25 revenue of ₹ 686.82 crore. This represent the growth of 3.65% The ebitda of Aarey Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 2.67 crore. This represent the decline of -100% The ebitda of Alivus Life Sciences Ltd for the Mar '26 is ₹ 237.31 crore as compare to the Dec '25 ebitda of ₹ 219.54 crore. This represent the growth of 8.09% The net profit of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 1.24 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Alivus Life Sciences Ltd changed from ₹ 111.48 crore to ₹ 162.66 crore over 8 quarters. This represents a CAGR of 20.79% The Dividend Payout of Aarey Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Alivus Life Sciences Ltd changed from 61.46 % on March 2022 to 12.62 % on March 2025 . This represents a CAGR of -32.68% over 4 years .

About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Limited was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Private Limited.
The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana.
In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the Company and it was converted into public limited company.
Also, the name of the company was changed from Niharika Textiles & Chemicals Private Limited to Aarey Drugs & Pharmaceuticals Limited. The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API's Drugs, Food Colours and Flavours.
The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business.

About Alivus Life Sciences Ltd

Alivus Life Sciences Limited was initially established as 'Zorg Laboratories Private Limited', on June 23, 2011 and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra in Pune.
Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited' and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The name of the Company has now changed to 'Alivus Life Sciences Limited' on January 20, 2025. Nirma Limited is a Subsidiary of the Company.
The Company is engaged in the business of development, manufacture and marketing of Active Pharmaceutical Ingredients(APIs). In 2001, Glenmark Pharmaceuticals established its API business.

FAQs for the comparison of Aarey Drugs & Pharmaceuticals Ltd and Alivus Life Sciences Ltd

Which company has a larger market capitalization, Aarey Drugs & Pharmaceuticals Ltd or Alivus Life Sciences Ltd?

Market cap of Aarey Drugs & Pharmaceuticals Ltd is 258 Cr while Market cap of Alivus Life Sciences Ltd is 12,824 Cr

What are the key factors driving the stock performance of Aarey Drugs & Pharmaceuticals Ltd and Alivus Life Sciences Ltd?

The stock performance of Aarey Drugs & Pharmaceuticals Ltd and Alivus Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarey Drugs & Pharmaceuticals Ltd and Alivus Life Sciences Ltd?

As of May 18, 2026, the Aarey Drugs & Pharmaceuticals Ltd stock price is INR ₹90.99. On the other hand, Alivus Life Sciences Ltd stock price is INR ₹1044.85.

How do dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Alivus Life Sciences Ltd compare?

To compare the dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Alivus Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.